Literature DB >> 22531094

Association between obesity, hypertriglyceridemia and low hepatitis B viral load.

C-H Chiang1, H-I Yang, C-L Jen, S-N Lu, L-Y Wang, S-L You, J Su, U H Iloeje, C-J Chen.   

Abstract

OBJECTIVE: This study aimed to investigate the metabolic risk factors of high hepatitis B viral load.
DESIGN: Large-scale, community-based cross-sectional study.
SUBJECTS: A total of 3587 hepatitis B virus (HBV)-infected participants without liver cirrhosis at study entry were investigated. High HBV viral load was defined as a serum level 10(4) copies per ml for hepatitis B e antigen (HBeAg) seronegatives or 10(8) copies per ml for HBeAg seropositives.
RESULTS: Among HBeAg seropositives (n=545), high HBV viral load was reversely associated with extreme obesity (odds ratio (OR), 0.30; 95% confidence interval (CI), 0.13-0.68; P=0.004) or central obesity (OR, 0.53; 95% CI, 0.34-0.82; P=0.004) after adjustment for gender, hypertriglyceridemia, hyperuricemia and history of hypertension. High HBV viral load remained significantly inversely associated with extreme obesity (OR, 0.17; 95% CI, 0.05-0.63; P=0.008) and central obesity (OR, 0.44; 95% CI, 0.25-0.78; P=0.005) in male HBeAg-seropositive participants in stratification analyses by gender. Among HBeAg seronegatives (n=3042), however, high HBV viral load was inversely associated with hypertriglyceridemia (OR, 0.74; 95% CI, 0.61-0.89, P=0.002) after adjustment for age, gender, high serum alanine aminotransferase level, and extreme obesity or central obesity. High HBV viral load was still inversely associated with hypertriglyceridemia in both female (OR, 0.70; 95% CI, 0.50-0.97; P=0.041) and male (OR, 0.75; 95% CI, 0.60-0.94; P=0.011) HBeAg-seronegative participants.
CONCLUSION: Extreme obesity and central obesity were associated with a low prevalence of high HBV viral load in HBeAg seropositives, especially in men; while hypertriglyceridemia was associated with a low prevalence of high viral load in HBeAg seronegatives in both women and men.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22531094     DOI: 10.1038/ijo.2012.63

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  15 in total

Review 1.  Association between hepatitis B and metabolic syndrome: Current state of the art.

Authors:  Peter Jarcuska; Sylvia Drazilova; Jan Fedacko; Daniel Pella; Martin Janicko
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 2.  Association between metabolic factors and chronic hepatitis B virus infection.

Authors:  Chien-Hsieh Chiang; Kuo-Chin Huang
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

3.  P2X7 Activation Enhances Lipid Accumulation During Adipocytes Differentiation Through Suppressing the Expression of Sirtuin-3, Sirtuin-5, and Browning Genes.

Authors:  Chien-Hsieh Chiang; Ching-Yuan Cheng; Yi-Ting Lien; Kuo-Chin Huang; Wan-Wan Lin
Journal:  Front Pharmacol       Date:  2022-04-06       Impact factor: 5.988

4.  Inverse association between hepatitis B virus infection and fatty liver disease: a large-scale study in populations seeking for check-up.

Authors:  Yuan-Lung Cheng; Yuan-Jen Wang; Wei-Yu Kao; Ping-Hsien Chen; Teh-Ia Huo; Yi-Hsiang Huang; Keng-Hsin Lan; Chien-Wei Su; Wan-Leong Chan; Han-Chieh Lin; Fa-Yauh Lee; Jaw-Ching Wu
Journal:  PLoS One       Date:  2013-08-22       Impact factor: 3.240

5.  Associated Factors for Metabolic Syndrome in the Older Adults with Chronic Virus Hepatitis in the Community.

Authors:  Yuan-Hung Kuo; Ming-Chao Tsai; Kwong-Ming Kee; Kuo-Chin Chang; Jing-Houng Wang; Chun-Yin Lin; Sheng-Che Lin; Sheng-Nan Lu
Journal:  PLoS One       Date:  2016-05-13       Impact factor: 3.240

6.  Hepatitis B virus infection and the risk of nonalcoholic fatty liver disease: a meta-analysis.

Authors:  Jianping Xiong; Haoaohai Zhang; Yaqin Wang; Anqiang Wang; Jin Bian; Hanchun Huang; Ying Zheng; Xinting Sang; Yiyao Xu; Xin Lu; Haitao Zhao
Journal:  Oncotarget       Date:  2017-11-03

7.  Sexual Dimorphic Metabolic Alterations in Hepatitis C Virus-infected Patients: A Community-Based Study in a Hepatitis B/Hepatitis C Virus Hyperendemic Area.

Authors:  Jing-Hong Hu; Mei-Yen Chen; Chau-Ting Yeh; Huang-Shen Lin; Ming-Shyan Lin; Tung-Jung Huang; Ming-Ling Chang
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

8.  The Relationship of Diabetes and Smoking Status to Hepatocellular Carcinoma Mortality.

Authors:  Chien-Hsieh Chiang; Chia-Wen Lu; Hsieh-Cheng Han; Shou-Hung Hung; Yi-Hsuan Lee; Kuen-Cheh Yang; Kuo-Chin Huang
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.817

Review 9.  Diabetes Mellitus and Risk of Hepatocellular Carcinoma.

Authors:  Xu Li; Xiaocong Wang; Pujun Gao
Journal:  Biomed Res Int       Date:  2017-12-12       Impact factor: 3.411

10.  Unawareness of Hepatitis B Virus Infection confers on Higher Rate of Metabolic Syndrome: A Community-based Study.

Authors:  Cheng-Hung Chien; Li-Wei Chen; Chih-Lang Lin; Su-Wie Chang; Yu-Chiau Shyu; Kuan-Fu Chen; Shuo-Wei Chen; Ching-Chih Hu; Chia-Ying Yu; Rong-Nan Chien
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.